OrbusNeich is a global company that designs, develops, manufactures and markets innovative medical devices for the treatment of vascular diseases. Through an extensive portfolio of high-performance stents and balloons, OrbusNeich provides proven solutions to interventional cardiologists worldwide. OrbusNeich has developed and commercialized the first Pro-Healing stents, the Genous™ Bio-engineered R stent and Genous™ Bio-engineered Cobalt Chromium stent , as well as bare metal stents and balloons marketed under the names of Azule™, R stent™, Scoreflex™, Sapphire™ II, Sapphire™ and, Sapphire™ NC. Most importantly, OrbusNeich has introduced COMBO™, the world’s first dual therapy stent that accelerates endothelial coverage and controls neo-intimal proliferation through the combination of the Genous EPC capture technology with an abluminal sirolimus drug elution.
Medfit Hellas S.A. is OrbusNeich's exclusive representative in Greece.
The COMBO Dual Therapy Stent accelerates endothelial coverage and controls neo-intimal proliferation, providing a safe, no compromise solution for you and your patient.
Effective, Proven Pro-Healing Stent Technology, Now on a Thin Cobalt Chromium Stent
The Genous Bio-engineered Cobalt Chromium Stent combines thin stent struts, dual helix design and EPC capture technology to protect against thrombus and minimize restenosis by accelerating the natural healing process.
CROSS and RE-CROSS simply with ease
Sapphire II Coronary Dilatation Catheter is a well-balanced balloon catheter that crosses lesions without boundaries.
The product is intelligently engineered to fit every need from treating tight lesions to negotiating through tortuous anatomies. The product portfolio includes a new 1.0 mm configuration; this balloon is ideal for penetrating severely narrowed lesions.